Mentor Adjunct Study for Silicone Gel-Filled Mammary Prosthesis (Adjunct)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00948948|
Expanded Access Status : Approved for marketing
First Posted : July 29, 2009
Last Update Posted : April 5, 2013
|Condition or disease||Intervention/treatment|
|Breast Reconstruction||Device: Silicone Gel-Filled Mammary Prostheses|
Objectives of this study are to gather safety data regarding short term, post-implant events and complications needed to support Premarket Approval (PMA) submissions for Mentor Silicone Gel-Filled Mammary Prostheses and to maintain a comprehensive record of the patient's ongoing medical history. The FDA has placed the devices in a regulatory category as a Class III device, pursuant to the Medical Device Amendments to the Federal Food and Drug Act which went into effect in May 1976. For devices in this class, FDA requires certain clinical data regarding the risks associated with mammary prostheses. Due to several issues surrounding possible risks of silicone gel-filled breast implants, the FDA has mandated specific clinical study requirements to further assess possible risks and complications of silicone devices. Clinical data collected via this study will supplement data which will be collected in more extensive "Core" studies for breast reconstruction and augmentation procedures.
Primary Objective - Safety Assessment
Specifically, data collected during this study will provide risk and complication data with regard to short-term use of silicone breast implants. This safety assessment will include, but is not limited to:
- Incidence of capsular contracture
- Occurrence of complications such as infection and seroma
- Rupture rates for the implant
This study is not intended to assess rare, long-term or speculative conditions which are not proven clinically to be associated with mammary prostheses, such as their relationship to Connective Tissue Disorders, an increased risk of cancer or teratogenic effects among breast implant patients. This study is also not intended to address issues regarding the effects of breast implants on mammography interpretation and occurrence of calcium deposits in the tissue surrounding the implant. However, data on these and other complications noted in this study, should they occur, will be recorded and analyzed with regard to the objective of the study.
|Study Type :||Expanded Access|
|See clinical trials of the intervention/treatment in this expanded access record.|
|Official Title:||Mentor Adjunct Study for Silicone Gel-Filled Mammary Prosthesis|
- Device: Silicone Gel-Filled Mammary Prostheses
Mentor Gel-Filled Mammary Prostheses are comprised of a shell made of medical grade silicone elastomer. Gel-filled implant devices manufactured by Mentor will be used in this study:
- Gel-filled device which is available in smooth surface and textured surface (Siltex®)
- Becker Expander/Mammary Prosthesis which is available in both the smooth and the textured (Siltex) version
Both of these devices were originally indicated for both augmentation and reconstruction mammaplasty procedures, however for purposes of this study, indications are for reconstruction only.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00948948
|United States, California|
|Mentor Worldwide LLC|
|Santa Barbara, California, United States, 93111|
|Study Director:||Sue Schwefel||Mentor Worldwide, LLC|